New study reveals how antipsychotics pass to baby during pregnancy and breastfeeding

NCT ID NCT05766007

First seen Feb 19, 2026 · Last updated Jun 14, 2026 · Updated 23 times

Summary

This study looked at 168 pregnant or breastfeeding women with serious mental health conditions like schizophrenia or mania who were already taking long-acting injectable antipsychotics. Researchers measured how much of the drug was in the mother's blood and breastmilk, and how much reached the baby. The goal is to help doctors make better decisions about using these medications during pregnancy and while breastfeeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Federal Medical Centre

    Makurdi, Benue State, Nigeria

  • Federal Neuropsychiatric Hospital

    Kaduna, Kaduna State, Nigeria

  • Federal Neuropsychiatric Hospital

    Yaba, Lagos, Nigeria

  • Neuropsychiatric Hospital

    Abeokuta, Ogun State, Nigeria

  • Neuropsychiatric Specialist Hospital

    Akure, Ondo State, Nigeria

  • Obafemi Awolowo University Teaching Hospital

    Ile-Ife, Osun State, Nigeria

Conditions

Explore the condition pages connected to this study.